Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers
Sun Pharma's Dadra facility receives OAI status from US FDA
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The company will respond to the Warning Letter within the stipulated timelines
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
The company plans to add 1700 beds by FY27 through the organic route
International Business is expected to register double-digit growth in constant currency terms
The average time of dilation lasts three to eight hours
Subscribe To Our Newsletter & Stay Updated
